🧬 Not sure where to start? Try searching for your diagnosis above or visit the “Diseases” section.

FDA grants fast track status to Allogene’s autoimmune therapy

FDA Grants Fast Track Status to Allogene's autoimmune therapy

Allogene Therapeutics, a biotech company, has received “Fast Track” status from the U.S. Food and Drug Administration (FDA) for its new therapy, ALLO-329, aimed at treating autoimmune diseases like systemic lupus erythematosus (SLE), immune-mediated inflammatory diseases (IIM), and systemic sclerosis (SSc). This designation is granted to expedite the development and review of drugs that address […]

Autoimmune Archive
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.